Skip to main content
Log in

Importance of surgical expertise in septal myectomy for obstructive hypertrophic cardiomyopathy

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objective

In 2011, a multidisciplinary hypertrophic cardiomyopathy (HCM) program with a dedicated myectomy surgeon was implemented at our institution. We hypothesized that a dedicated approach allows better identification and management of mitral regurgitation (MR) during septal myectomy (SM) for obstructive HCM with significant mitral regurgitation.

Methods

Between 2006 and 2018, 181 patients had SM at our institution. This study consists of 53 patients with preoperative moderate or greater MR associated with systolic anterior motion who underwent isolated SM with or without mitral intervention. Patients were divided into those who underwent SM by a dedicated myectomy surgeon (group D, n = 31) or by a non-dedicated surgeon (group ND, n = 22). Primary outcome of interest was rate of mitral valve replacement (MVR) at SM. Secondary outcomes include in-hospital mortality, need for permanent pacemaker, mitral valve reoperation, and residual MR and left ventricular outflow tract gradient on postoperative echocardiography.

Results

12 patients (55%) had a concomitant MVR during septal myectomy in group ND compared to 2 patients (6%) in group D (p < 0.01). Among patients who did not undergo MVR, patients in group D less commonly had residual MR than patients in ND after SM (p < 0.01). Group D had 100% survival with NYHA class I in 94% patients at follow-up visit (p = 0.01). Reoperation for MVR was required in four patients in group ND vs. none in group D (p < 0.01).

Conclusions

A dedicated surgeon is able to spare the mitral valve in patients undergoing SM. This study emphasizes the importance of surgical expertise in this cohort.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

SM:

Septal myectomy

HCM:

Hypertrophic cardiomyopathy

LVOT:

Left ventricular outflow tract

MV:

Mitral valve

MVR:

Mitral valve replacement

SAM:

Systolic anterior motion

TEE:

Transesophageal echocardiogram

TTE:

Transthoracic echocardiogram

References

  1. Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015. https://doi.org/10.1016/j.jacc.2015.01.019.

    Article  PubMed  Google Scholar 

  2. Maron BJ. Hypertrophic Cardiomyopathy. Lancet. 1997. https://doi.org/10.1148/radiol.10090526.

    Article  PubMed  Google Scholar 

  3. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary. J Thorac Cardiovasc Surg. 2011;142(6):1303–38. https://doi.org/10.1016/j.jtcvs.2011.10.019.

    Article  PubMed  Google Scholar 

  4. Maron BJ, Dearani JA, Ommen SR, et al. Low operative mortality achieved with surgical septal myectomy role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction. J Am Coll Cardiol. 2015. https://doi.org/10.1016/j.jacc.2015.06.1333.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Minakata K, Dearani JA, Schaff HV, O’Leary PW, Ommen SR, Danielson GK. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 2005;80(3):851–6. https://doi.org/10.1016/j.athoracsur.2005.03.108.

    Article  PubMed  Google Scholar 

  6. Maron BJ, Dearani JA, Maron MS, et al. Why we need more septal myectomy surgeons: an emerging recognition. J Thorac Cardiovasc Surg. 2017;154(5):1681–5. https://doi.org/10.1016/j.jtcvs.2016.12.038.

    Article  PubMed  Google Scholar 

  7. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013. https://doi.org/10.1016/S0140-6736(12)60397-3.

    Article  PubMed  Google Scholar 

  8. Takayama H, Chung WK, Maurer MS, Ginns JN. Hypertrophic cardiomyopathy: new approaches and a time to reappraise older approaches. J Thorac Cardiovasc Surg. 2016;152(4):983–8. https://doi.org/10.1016/J.JTCVS.2016.06.034.

    Article  PubMed  Google Scholar 

  9. Morrow AG, Fogarty TJ, Hannah H, Braunwald E. Operative treatment in idiopathic hypertrophic subaortic stenosis. Circulation. 1968;37:589–96.

    Article  CAS  Google Scholar 

  10. Schaff HV, Said SM. Transaortic extended septal myectomy for hypertrophic cardiomyopathy. Oper Tech Thorac Cardiovasc Surg. 2012;17(4):238–50. https://doi.org/10.1053/j.optechstcvs.2012.04.002.

    Article  Google Scholar 

  11. Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The mitral valve in obstructive hypertrophic cardiomyopathy a test in context. J Am Coll Cardiol. 2016;67(15):1846–58. https://doi.org/10.1016/j.jacc.2016.01.071.

    Article  PubMed  Google Scholar 

  12. Dearani JA, Ommen SR, Gersh BJ, Schaff HV, Danielson GK. Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med. 2007. https://doi.org/10.1038/ncpcardio0965.

    Article  PubMed  Google Scholar 

  13. Collis R, Watkinson O, O’Mahony C, et al. Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Eur J Heart Fail. 2017. https://doi.org/10.1002/ejhf.1038.

    Article  PubMed  Google Scholar 

  14. Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg. 2004;127(2):481–9. https://doi.org/10.1016/j.jtcvs.2003.09.040.

    Article  PubMed  Google Scholar 

  15. Kato TS, Takayama H, Yoshizawa S, et al. Cardiac transplantation in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2012. https://doi.org/10.1016/j.amjcard.2012.04.030.

    Article  PubMed  Google Scholar 

  16. Takayama H, Yu SN, Sorabella R, et al. Virtual septal myectomy for preoperative planning in hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2018. https://doi.org/10.1016/J.JTCVS.2018.10.138.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fukuhara S, Edwards S, Kurlansky P, Takayama H. Bimanual examination for septal myectomy for hypertrophic cardiomyopathy. Interact Cardiovasc Thorac Surg. 2014;19(5):735–7. https://doi.org/10.1093/icvts/ivu251.

    Article  PubMed  Google Scholar 

  18. Panaich SS, Badheka AO, Chothani A, et al. Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998–2010]). Am J Cardiol. 2014. https://doi.org/10.1016/j.amjcard.2014.07.075.

    Article  PubMed  Google Scholar 

  19. Kim LK, Swaminathan RV, Looser P, et al. Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy. JAMA Cardiol. 2016. https://doi.org/10.1001/jamacardio.2016.0252.

    Article  PubMed  Google Scholar 

  20. Said SM, Schaff HV. Surgical treatment of hypertrophic cardiomyopathy. Semin Thorac Cardiovasc Surg. 2013. https://doi.org/10.1053/j.semtcvs.2014.01.001.

    Article  PubMed  Google Scholar 

  21. Hong JH, Schaff HV, Nishimura RA, et al. Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures. J Am Coll Cardiol. 2016. https://doi.org/10.1016/j.jacc.2016.07.735.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Takayama H, Nguyen S, Weiner SD. Commentary: watch how the mitral valve is repaired at septal myectomy (and root replacement). J Thorac Cardiovasc Surg. 2020. https://doi.org/10.1016/j.jtcvs.2019.09.128.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroo Takayama.

Ethics declarations

Conflict of interest

Yuichi Shimada has received research funding from the American Heart Association. The remaining authors have no financial disclosures.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, S.N., Nakanishi, K., Ginns, J.N. et al. Importance of surgical expertise in septal myectomy for obstructive hypertrophic cardiomyopathy. Gen Thorac Cardiovasc Surg 68, 1094–1100 (2020). https://doi.org/10.1007/s11748-020-01320-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-020-01320-7

Keywords

Navigation